000 | 01300 a2200325 4500 | ||
---|---|---|---|
005 | 20250517044004.0 | ||
264 | 0 | _c20160502 | |
008 | 201605s 0 0 eng d | ||
022 | _a1537-6591 | ||
024 | 7 |
_a10.1093/cid/civ460 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChilukuri, Dakshina | |
245 | 0 | 0 |
_aThe Hollow Fiber System Model in the Nonclinical Evaluation of Antituberculosis Drug Regimens. _h[electronic resource] |
260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cAug 2015 |
||
300 |
_aS32-3 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntitubercular Agents _xadministration & dosage |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
650 | 0 | 4 |
_aTuberculosis _xdrug therapy |
700 | 1 | _aMcMaster, Owen | |
700 | 1 | _aBergman, Kimberly | |
700 | 1 | _aColangelo, Philip | |
700 | 1 | _aSnow, Kerry | |
700 | 1 | _aToerner, Joseph G | |
773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 61 Suppl 1 _gp. S32-3 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/cid/civ460 _zAvailable from publisher's website |
999 |
_c25122393 _d25122393 |